Erratum: Efficacy and safety of tadalafil once daily: Considerations for the practical application of a daily dosing option (Current Medical Research & Opinion (2008) 24 (3383-3392) DOI: 10.1185/03007990802498440);Efficacy and safety of tadalafil once daily: Considerations for the practical application of a daily dosing option

Current Medical Research and Opinion

Volumn 24, Issue 12, 2008, Pages 3383-3392

  Donatucci, Craig F ^a   Wong, David G ^b   Giuliano, Francois ^c   Glina, Sidney ^d   Dowsett, Sherie A ^b   Watts, Steven ^b   Sorsaburu, Sebastian ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d HOSPITAL IPIRANGA   (Brazil)

Author keywords

Erectile dysfunction; Once daily; PDE5 inhibitor; Tadalafil

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; HEMOGLOBIN A1C; ORGANIC NITRATE; PLACEBO; TADALAFIL; CARBOLINE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR;

ABDOMINAL PAIN; ANGINA PECTORIS; AREA UNDER THE CURVE; BACKACHE; BRONCHITIS; CLINICAL TRIAL; COUGHING; DIABETIC PATIENT; DISEASE DURATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; GLYCEMIC CONTROL; HEADACHE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; INFLUENZA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MYALGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; RECOMMENDED DRUG DOSE; REVIEW; RHINOPHARYNGITIS; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS; UPPER RESPIRATORY TRACT INFECTION; VIRAL GASTROENTERITIS; ADULT; AGED; MIDDLE AGED; PATHOPHYSIOLOGY; SAFETY;

ADULT; AGED; CARBOLINES; CLINICAL TRIALS AS TOPIC; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; SAFETY;

EID: 62349122858     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007991003598343     Document Type: Erratum

References (29)

1. National Institute of Health NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90
2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urology 1994;151:54-61 (Pubitemid 24046934)
3. Perelman M, Shabsigh R, Seftel A, et al. Attitudes of men with erectile dysfunction: a cross-national survey. J Sex Med 2005;2:397-406 (Pubitemid 40744381)
4. Fisher WA, Rosen RC, Eardley I, et al. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005;2:675-84 [erratum appears in J Sex Med 2006;3(1):189] (Pubitemid 41742928)
5. Cameron A, Rosen RC, Swindle RW. Sexual and relationship characteristics among an internet-based sample of U.S. men with and without erectile dysfunction. J Sex Marital Ther 2005;31:229-242 (Pubitemid 40594094)
6. Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Plymouth: Erectile Dysfunction, 2007
7. Porst H, Padma-Nathan H, Giuliano F, et al. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology 2003;62:121-125 (Pubitemid 36802084)
8. Young JM, Feldman RA, Auerbach SM, et al. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. J Andrology 2005;26:310-318 (Pubitemid 40628966)
9. Carson CC, Rajfer J, Eardley I, et al. The efficacy and safety of tadalafil: an update. BJU International 2004;93:1276-1281 (Pubitemid 38823952)
10. Hatzichristou D, Gambla M, Rubio-Aurioles E, et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabetic Med 2008;25:138-146 (Pubitemid 351297651)
11. Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 2006;50:351-359 (Pubitemid 44038075)
12. Rajfer J, Aliotta PJ, Steidle CP, et al. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 2007;19:95-103 (Pubitemid 46067355)
13. Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346-351 (Pubitemid 29367263)
14. Mulhall JP. Deciphering erectile dysfunction drug trials. J Urology 2003;170:353-358 (Pubitemid 36870199)
15. Porst H, Rajfer J, Casabe AR, et al. Long term safety and efficacy of tadalafil 5mg dosed once daily in men with erectile dysfunction. J Sex Med 2008;5:2160-2169
16. Gore J Rajfer J. Diabetes and erectile dysfunction. Curr Sex Health Rep 2004;1:87-91
17. Saenz de Tejada, I, Anglin G, Knight JR, et al. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 2002;25:2159-2164 (Pubitemid 41071021)
18. Fonseca V, Seftel A, Denne J, et al. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 2004;47:1914-1923 (Pubitemid 40110198)
19. Rendell MS, Rajfer J, Wicker PA, et al. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999;281:421-426 (Pubitemid 29069439)
20. Ziegler D, Merfort F, van Ahlen H, et al. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction. J Sex Med 2006;3:883-891 (Pubitemid 44269544)
21. Eli Lilly and Company. US Cialis Prescribing Information 2008
22. Hellstrom WJ, Overstreet JW, Yu A, et al. Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones. J Urology 2003;170:887-891 (Pubitemid 36999583)
23. Hellstrom WJ, Gittelman M, Jarow J, et al. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study. Eur Urol 2008;53:1058-1065
24. Guillaume M, Lonsdale F, Darstein C, et al. Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects. J Clin Pharmacol 2007;47:1303-1310 (Pubitemid 47459669)
25. Burchardt M, Burchardt T, Baer L, et al. Hypertension is associated with severe erectile dysfunction. J Urology 2000;164:1188-1191 (Pubitemid 30703534)
26. Ponholzer A, Temml C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 1985;47:80-85
27. Kloner RA, Jackson G, Hutter AM, et al. Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing. Am J Cardiol 2006;97:1778-1784 (Pubitemid 43833438)
28. National Heart, Lung and Blood Institute Incidence & Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. 2006
29. Lue T. A patient's goal-directed approach to erectile dysfunction and Peyronie's disease. Can J Urol 1995;2(Supp 1):13-17